Translation and validation of the arabic version of the myasthenia gravis activities of daily living scale

Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire

(2017) Mohammed H. Alanazy et al.   MUSCLE & NERVE

QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis

(2017) James F. Howard et al.   MUSCLE & NERVE

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r

(2016) Ted M. Burns et al.   MUSCLE & NERVE

MG-ADL: Still a relevant outcome measure

(2011) Srikanth Muppidi et al.   MUSCLE & NERVE

A point of minimal important difference (MID): a critique of terminology and methods

(2011) Madeleine T King   Expert Review of Pharmacoeconomics & Outcomes Research

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

(2010) Ted M Burns et al.   MUSCLE & NERVE

The MG Composite: A valid and reliable outcome measure for myasthenia gravis

(2010) T. M. Burns et al.   NEUROLOGY

Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis

(2008) Gil I. Wolfe et al.   MUSCLE & NERVE

Construction of an efficient evaluative instrument for Myasthenia Gravis: The MG composite

(2008) Ted M. Burns et al.   MUSCLE & NERVE

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

(2008)   NEUROLOGY